Study of the Interprofessional Reproducibility of a Clinical Observation Scale for the Development of Very Premature Infants

NCT ID: NCT07169110

Last Updated: 2025-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-22

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The research concerns the study of the interprofessional reproducibility of a grid for observing the development of premature infants from 1 to 6 months corrected age. No tool is available to characterize the mechanisms of early developmental processes and their deviations. We propose an analytical observation grid of developmental mechanisms in the first few months, in order to identify warning signs of developmental deviations and help define the nature and type of early care for vulnerable infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Improving the development of premature babies is a challenge. Developmental disabilities are common. Brain damage accounts for only a small proportion of disorders. Other factors have a major influence on the outcome: immaturity, an intrusive and stressful hospital environment, and parental socio-psychological conditions. Early sensory-motor disorders disrupt development. The high degree of cerebral plasticity in infants means that early care is essential if developmental trajectories are to be improved. Intervention programmes are heterogeneous. Meta-analyses therefore make only limited comparisons. The cognitive and behavioural benefits are variable. Motor benefits are low. No tools are available to determine the mechanisms of early developmental processes.

The SPIN-NA grid is a scale for analytical observation of developmental processes from 1 to 6 months corrected age to identify early warning signs and determine early care (nature, areas of care, objectives). The aim is to study the inter-professional reproducibility of the grid. This validation stage is essential if the grid is to serve as a reference tool in psychomotricity for vulnerable newborns.

Premature babies born between 27 and 32 gestational weeks will be assessed using the SPIN-NA grid by 5 experienced psychomotor-therapists, on the basis of videos taken at home between 1 and 6 months corrected age, by the creators of the grid. Each child was filmed only once. The inter-observer agreement should be at least 70% for the 8 observation axes defined in the SPIN-NA grid.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prematurity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Premature infant early development early care intervention early evaluation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SPIN-NA Evaluation

Infants evaluated by SPIN-NA grid

SPIN-NA Developmental Observation Grid Assessment via Home-Based Standardized Video Recording

Intervention Type OTHER

The SPIN-NA intervention consists of an analytical assessment of development using a standardized clinical observation grid.

Infants are filmed at home once between 1 and 6 months of corrected age in their family environment by the creators of the grid.

The filmed observation includes structured observation scenarios designed to assess eight areas of development:

stress signals, physiological and tonic regulation, perceptual abilities of different sensory channels, exploratory appetite, manipulative activities, child interactions and communication, emotional expressions and expressiveness, parent-child interactions: parental adaptation to the child's behavior.The videos are evaluated independently by five experienced psychomotor therapists trained together in the use of the SPINNA grid. No treatment or physical intervention is administered; the intervention is observational and non-invasive, aimed at validating the reproducibility of the grid in a real-world context.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SPIN-NA Developmental Observation Grid Assessment via Home-Based Standardized Video Recording

The SPIN-NA intervention consists of an analytical assessment of development using a standardized clinical observation grid.

Infants are filmed at home once between 1 and 6 months of corrected age in their family environment by the creators of the grid.

The filmed observation includes structured observation scenarios designed to assess eight areas of development:

stress signals, physiological and tonic regulation, perceptual abilities of different sensory channels, exploratory appetite, manipulative activities, child interactions and communication, emotional expressions and expressiveness, parent-child interactions: parental adaptation to the child's behavior.The videos are evaluated independently by five experienced psychomotor therapists trained together in the use of the SPINNA grid. No treatment or physical intervention is administered; the intervention is observational and non-invasive, aimed at validating the reproducibility of the grid in a real-world context.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female child born between 27 and 32 weeks of amenorrhea in a singleton pregnancy;
* Child hospitalized in the neonatology unit of Toulouse University Hospital;
* Family home within a 15 km radius of Toulouse to allow for home visits for filming;
* Parents with parental authority affiliated with a social security scheme or equivalent;
* Signature of the informed consent form by the parents with parental authority

Exclusion Criteria

* The child may participate in another study during the duration of this study, without an exclusion period.


* Child with a severe organic pathology detected during hospitalization and requiring specific and appropriate care for the diagnosed pathology;
* Child with a neurological complication: Grade 3 or 4 intraventricular hemorrhage, periventricular cavitary leukomalacia, excluding frontal leukomalacia;
* Child with a malformation or multiple malformations that impair the neurological prognosis;
* Child with genetic or metabolic diseases;
* Fetal alcohol syndrome;
* Parental authority holders under guardianship, curatorship, or legal protection;
* Any family condition that prevents compliance with the procedures set out in the study protocol, in the opinion of the investigator.
* Family members who do not speak French fluently, in order to ensure understanding of the system and the proposed care.
Minimum Eligible Age

1 Month

Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Corine Alberge

Role: STUDY_DIRECTOR

University Hospital of Toulouse

Nathalie Noack

Role: STUDY_DIRECTOR

University Hospital of Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Intensive care /neonatology Toulouse Hospital

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nadège Algans

Role: CONTACT

Phone: 0561777204

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Corinne Alberge

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ID-RCB : 2025-A00379-40

Identifier Type: OTHER

Identifier Source: secondary_id

RC31/25/0578

Identifier Type: -

Identifier Source: org_study_id